U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498803) titled 'Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger's Syndrome' on March 19.
Brief Summary: The present study seeks to provide pilot data on the safety and efficacy of medical therapy with sotatercept in patients with an established diagnosis of congenital heart disease and Eisenmenger syndrome.
CHASE is an interventional, single-arm, open-label study, that will enroll 40 patients with an established diagnosis of CHD and Eisenmenger syndrome. PAH background therapy may be present at the discretion of the investigators at the time of enrolment. CHASE will be performed only in countries where standard PAH...